Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Carlisle Companies | CSL | Nov 25, 2024 | 469.68 | +4.45 |
Carlyle Credit Income Fund | CCIA | Nov 25, 2024 | 25.99 | +0.15 |
Carlyle Credit Income Fund | CCIF | Nov 25, 2024 | 8.15 | -0.18 |
Carlyle Secured Lending | CGBD | Nov 25, 2024 | 17.00 | +0.89 |
CarMax | KMX | Nov 25, 2024 | 85.15 | +4.35 |
Carmell | CTCX | Nov 25, 2024 | 0.25 | +2.61 |
Carnival | CCL | Nov 25, 2024 | 25.19 | +1.16 |
Carnival ADR | CUK | Nov 25, 2024 | 22.73 | +0.93 |
CarParts.com | PRTS | Nov 25, 2024 | 1.07 | -4.46 |
Carpenter Technology | CRS | Nov 25, 2024 | 195.09 | +2.16 |
Carriage Services | CSV | Nov 25, 2024 | 40.65 | +3.67 |
Carrier Global | CARR | Nov 25, 2024 | 78.87 | +2.43 |
Cars.com | CARS | Nov 25, 2024 | 19.89 | +2.90 |
Carter Bankshares | CARE | Nov 25, 2024 | 18.95 | +1.61 |
Carters | CRI | Nov 25, 2024 | 55.28 | +2.43 |
Cartesian Growth II A | RENE | Nov 25, 2024 | 11.62 | 0.00 |
Cartesian Growth II Unit | RENEU | Nov 25, 2024 | 11.38 | 0.00 |
Cartesian Therapeutics | RNAC | Nov 25, 2024 | 17.91 | -5.09 |
Cartica Acquisition A | CITE | Nov 25, 2024 | 11.64 | 0.00 |
Carvana | CVNA | Nov 25, 2024 | 260.80 | +0.56 |
Carver Bancorp | CARV | Nov 25, 2024 | 1.67 | 0.00 |
Casella Waste Systems A | CWST | Nov 25, 2024 | 112.91 | +0.31 |
Caseys General Stores | CASY | Nov 25, 2024 | 426.69 | -0.28 |
CASI Pharmaceuticals | CASI | Nov 25, 2024 | 4.29 | -15.88 |
Cass Information Systems | CASS | Nov 25, 2024 | 44.83 | -0.30 |
Cassava Sciences | SAVA | Nov 25, 2024 | 4.29 | -83.78 |
Castellum | CTM | Nov 25, 2024 | 0.16 | +0.88 |
Castle Biosciences | CSTL | Nov 25, 2024 | 29.51 | -1.01 |
Castor Maritime | CTRM | Nov 25, 2024 | 3.56 | -0.28 |
Catalent | CTLT | Nov 25, 2024 | 61.29 | +0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.